@article{e14ba2b4273948d089dde3b64bdd404f,
title = "The Oracle of the Auricle?: Optimizing Serial Risk Stratification of Patients With Pulmonary Arterial Hypertension",
author = "Shelburne, {Nicholas J.} and Frantz, {Robert P.}",
note = "Funding Information: Financial/nonfinancial disclosures: The authors have reported to CHEST the following: N. J. S. reports research funding from Bayer; R. P. F. reports consulting, advisory board, and steering committee relationships with Altavant Sciences, Bayer, Gossamer Bio, Janssen, Tenax, ShouTi, Liquidia, United Therapeutics and UptoDate.",
year = "2022",
month = sep,
doi = "10.1016/j.chest.2022.05.034",
language = "English (US)",
volume = "162",
pages = "509--510",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "3",
}